Sector revisions Abbott Laboratories Buenos Aires S.E.

Stocks

End-of-day quote Buenos Aires S.E. 06/10/2026			5-day change	1st Jan Change
39,500.00 ^ARS	-1.89%		-3.04%	-17.33%

03:14pm	Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target	MT
10-05	Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ABBOTT LABORATORIES							26
	MEDTRONIC PLC							25
	STRYKER CORPORATION							26
	ESSILORLUXOTTICA							23
	CENCORA, INC.							12
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							13
	IDEXX LABORATORIES, INC.							12
	DEXCOM, INC.							26
	MEDLINE INC.							26
	ALCON INC.							17
	WEST PHARMACEUTICAL SERVICES, INC.							16
	GUARDANT HEALTH, INC.							25
	SARTORIUS STEDIM BIOTECH							14
	TERUMO CORPORATION							13
	STERIS PLC							8
	SONOVA HOLDING AG							19
	STRAUMANN HOLDING AG							19
	ZIMMER BIOMET HOLDINGS, INC.							22
	Average							19
	Weighted average by Cap.							21